Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 1123  
CASE REPORT
Year : 2014  |  Volume : 13  |  Issue : 2  |  Page : 142-143

Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease


Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona, USA

Correspondence Address:
Dr. Muaz M Abudiab
13400 E. Shea Blvd., Scottsdale, AZ 85259
USA
Login to access the Email id


DOI: 10.4103/1450-1147.139148

PMID: 25191132

Rights and Permissions

Regadenoson is a widely used and well-tolerated vasodilator agent for pharmacologic stress myocardial perfusing imaging. In patients at higher risk of adverse reactions such as those with end stage renal disease, it can be reversed with early administration of aminophylline. However, little is known about late administration of aminophylline. This case report describes the efficacy of late aminophylline use in patients with end stage renal disease. Possible explanations for the prolonged pharmacodynamic effect of regadenoson in this group are discussed.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1274    
    Printed42    
    Emailed0    
    PDF Downloaded237    
    Comments [Add]    

Recommend this journal